Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 8Other hematologic neoplasm 8Lymphoid 8Gastrointestinal 8Breast 7Myeloid 5Gynecologic 5Genitourinary 5CNS 5Sarcoma 4Plasma cell 4Head & Neck 4Other neoplasm 3Classical hematology 3Dermatologic 2Other solid neoplasm 1Endocrine 1

Conditions

Mesothelioma, Malignant 1

Interventions

Cisplatin 60Carboplatin 55Cyclophosphamide 47Pemetrexed 45Irinotecan 33pembrolizumab 32Paclitaxel 29Etoposide 29Gemcitabine 28Nivolumab 24Bevacizumab 24Interviews as Topic 23Vincristine 22Capecitabine 22Topotecan 20Filgrastim 20Early Intervention, Educational 20fludarabine 19Oxaliplatin 19Docetaxel 19Specimen Handling 18Drug Therapy 18Temozolomide 17Sorafenib 17Leucovorin 17Everolimus 17Educational Status 17Radiotherapy 16Methods 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Microarray Analysis × Other solid neoplasm × Clear all
NCT00897247 2014-03-05

Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite

Barbara Ann Karmanos Cancer Institute

Completed
494 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡